CL vs NDRA
Colgate-Palmolive Company (CL) versus ENDRA Life Sciences Inc (NDRA) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
ENDRA Life Sciences Inc (NDRA) is a diagnostics & research company listed on US.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
NDRA does not have a complete income-statement cache yet.
CL currently screens at market cap $70.88B and trailing P/E 34.3. NDRA currently screens at market cap $2.6M and trailing P/E 0.0.
Not investment advice. Open the CL and NDRA stock pages for the full models.
Not investment advice.